Advertisement
Screener

SANGAMO THERAPEUTICS, INC. (SGMOQ) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)

2.8 / 5 stars · 68/120 Roast Me

SANGAMO THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)

SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of -$1.80 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-02-28.

Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2017-02-28

  • SANGAMO THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
  • SANGAMO THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
  • SANGAMO THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
  • SANGAMO THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2015-03-31 was -$1.80M, a 3700.00% decline year-over-year.
  • SANGAMO THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2015 was -$1.80M, a 882.61% decline from fiscal 2014.
  • SANGAMO THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2014 was $230.00K, a 383233.33% increase from fiscal 2013.
  • SANGAMO THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2013 was $60.00.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$0.00
derived: sum of 2 quarters · filed 2017-02-28
$0.00
derived: sum of 3 quarters · filed 2017-02-28
-$1.80M
10-K · filed 2017-02-28
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30
$0.00
derived: sum of 2 quarters · filed 2015-10-30
-$1.80M
10-Q · filed 2015-10-30
-$1.70M
derived: sum of 4 quarters · filed 2016-02-18
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$1.80M
10-Q · filed 2015-08-06
-$1.70M
derived: sum of 3 quarters · filed 2016-02-18
-$1.65M
derived: sum of 4 quarters · filed 2016-02-18
2015-03-31-$1.80M
10-Q · filed 2015-04-28
-$1.70M
derived: sum of 2 quarters · filed 2016-02-18
-$1.65M
derived: sum of 3 quarters · filed 2016-02-18
-$1.62M
derived: sum of 4 quarters · filed 2016-02-18
2014-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-18
$150.00K
derived: sum of 2 quarters · filed 2016-02-18
$180.00K
derived: sum of 3 quarters · filed 2016-02-18
$230.00K
10-K · filed 2016-02-18
2014-09-30$50.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28
$80.00K
derived: sum of 2 quarters · filed 2014-10-28
$130.00K
10-Q · filed 2014-10-28
2014-06-30$30.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29
$80.00K
10-Q · filed 2014-07-29
2014-03-31$50.00K
10-Q · filed 2014-05-07
2013-12-31$60.00
10-K · filed 2014-02-24